Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

English health official says have been extracting extra doses of AstraZeneca vaccine

Wed, 13th Jan 2021 10:22

LONDON, Jan 13 (Reuters) - It is possible to get an extra
dose out of vials of AstraZeneca's COVID-19 vaccine as
well as the one made by Pfizer, the head of immunisation
at Public Health England (PHE) said on Wednesday.

In December, the health service gave doctors advice that
they could use extra doses of the Pfizer vaccine at their
discretion if they could be extracted, and on Wednesday Dr Mary
Ramsay said it was happening with AstraZeneca's shot too.

"We have been able to get more vaccine out of each vial, and
that's happened for the Pfizer vaccine and it's also happening
with the AstraZeneca vaccine. So that means overall, we've got
more vaccines to go around," she told lawmakers, adding that PHE
had bought the necessary needles "from the start".

"Really very early on we discovered that we're able to get
more out of the vials, which is excellent news."
(Reporting by Alistair Smout; editing by William James)

Related Shares

More News
Today 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.